Most recent investigations concerning the toxicological and ecotoxicological risk potentials of ionic liquids are predominantly focusing on the cation moieties. In this study we elucidate, whether the anion species commonly used in ionic liquids are exhibiting intrinsic cytotoxic effects and if these effects can be rationalised by thinking in terms of structure-activity relationships (T-SAR). As test system to measure the cell viability as toxicologically relevant endpoint the IPC-81 rat leukemia cell line and the WST-1 assay were employed. Our results show an anion effect in ionic liquids on cytotoxicity for 10 of 27 tested anions. For the remaining 17 anions from our test kit no significant effect was found. With respect to structure-activity relationships, lipophilicity and/or vulnerability to hydrolytic cleavage seem to be the key structural features leading to the observed anion cytotoxicity. We also conclude that the model of concentration addition may be useful to estimate the EC 50 values of ionic liquids that have not been tested or even synthesised yet. This can help to design not only task specific but also inherently safer ionic liquids.

No abstract

No abstract

For ionic liquids only few toxicological and/or ecotoxicological data are available until now. A strategy is presented which aims at an environmental risk assessment of chemicals, using a combination of structure-activity relationships (SAR), toxicological and ecotoxicological tests and modelling. The parts "test-kit-concept" and "multidimensional risk analysis" are described in detail by means of selected imidazolium ionic liquids. The iterative process of this strategy offers a tool for sustainable product design.

Motivated by the prevailing need for a sustainable development and taking the principles of Green Chemistry as a starting point, the present paper describes new and updated findings regarding a sustainable product design for ionic liquids. The focus is on environmental risk. Nevertheless, cytotoxicity testing and first indicative results from a genotoxicity study extend present knowledge also with regard to possible effects on humans. The structural variability of commercially available ionic liquids as well as the abundance of theoretically accessible ionic liquids is illustrated and the consequences for an integrated risk assessment accompanying the development process are discussed. The side chain effect on toxicity for imidazolium type ionic liquids was confounded by more complex biological testing. Also, an influence of an anion on cytotoxicity is shown for the first time. Testing of presumed metabolites of the imidazolium type cations showed a significantly lower biological activity in cytotoxicity studies than their parent compounds. The importance of a purity assessment for ionic liquids is pointed out and a collection of methods that is believed to be adequate is presented. In addition to risk analysis, the use of life cycle analysis for the multi-objective problem of designing ionic liquids is sketched and an eco-design scheme for ionic liquids is proposed. In conclusion, the paper illustrates the complex nature of the development processes ionic liquids are currently undergoing and provides guidance on which aspects have to be kept in mind.